Effect of Direct Acting Anti-Hepatitis C Drugs on the Heart

Hematological Effects of Antiviral Drugs for Hepatitis C Virus

Effect of direct acting antiviral treatment (DAAs), as a new treatment of chronic viral hepatitis C on patients with heart failure

SHORT AND LONG TERM CARDIOTOXICITY OF SOFOSBUVIR AND DACLATASVIR ASSOCIATED WITH LIPID PROFILE ABNORMALITIES

EFFECT OF HCV DIRECT ANTIVIRAL AGENTS ON PORTAL CIRCULATION HEMODYNAMICS IN CIRRHOTIC PATIENTS

Effect of Direct Acting Anti-viral Agents on Insulin Resistance in Chronic HCV Patients

Effect of Treating Chronic Hepatitis C Infection with Direct-Acting Antivirals on The Risk of Recurrence Hepatocellular Carcinoma

Effect of Treatment of Hepatitis C by Directly Acting Antivirals (DAA) on Chronic Hepatitis C, B Coinfected Patients

Effect of Direct-Acting Antivirals on Lipid and Glucose Metabolism in Chronic HCV Patients

Short term follow-up of clinical outcome of patients with heart failure and associated hepatitis C virus infection